Recruiting
Systemic scleroderma
RecruitingSafety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
Registered drug
Safety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
Registered drug
- Disease:Systemic scleroderma
- Substances:MTX-474Sodium Chloride
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:MTX-474



